Summary: Shares Scotiabank Outperform reiteration on ASTS with $45.40 PT, citing Bezos meeting speculation and potential Amazon/Blue Origin equity tie-up.

AST SPACEMOBILE $ASTS reiterated at 'Outperform' at Scotiabank, with a $45.40 price-target.

Analyst Andres Coello speculates: "Could Jeff Bezos become an ASTS investor?"

"OUR TAKE: Positive. ASTS rallied yesterday after Ms. Adriana Cisneros posted a picture on Instagram showing the three of them together and titled “Amazing things are happening at AST & Science + @blueorigin”. The meeting’s location was not disclosed, but while Avellan and Cisneros are wearing a guest badges, Bezos is not. Only a few days ago, Blue Origin management visited the ASTS headquarters in Texas.

Cisneros was ASTS’s first-ever institutional investor and is currently a board member. In November 2024, ASTS announced that Bezos’ rocket company Blue Origin will handle the launch of up to 45 BB2 satellites with options to launch a further 15. Blue Origin’s New Glenn rocket is expected to handle up to 8 satellites per launch, making ASTS one of Blue Origin’s top customers. We doubt this was the sole reason why Mr. Bezos met with Avellan.

There are major areas of opportunity where they could collaborate, particularly regarding Amazon’s Project Kuiper, which intends to address the fixed broadband opportunity. This is an entirely different segment to DTC, making a tieup between the two an interesting alternative, especially as there are 5x more wireless connections than fixed globally.

Could Jeff Bezos become an ASTS investor? This is a possibility widely discussed by investors and analysts, in no small measure because Bezos is one of the world’s top space investors.

The agreement with ASTS is shown on the Blue Origin webpage as one of the company’s top-three recent developments (e.g. they clearly see ASTS as a leading player). The highly specialized RF technology ASTS has developed, which is protected by thousands of patents, represent a formidable barrier to entry for newcomers, including Kuiper. While Amazon intends to invest US$13B to US$16B in the Kuiper constellation of 3,236 satellites, the current market capitalization of ASTS stands at only US$8.3B. However, our revenue projection for ASTS is actually larger than for Kuiper at US$30B by 2033 vs. the US$25B estimated for Kuiper by Scotiabank GBM Amazon analyst Nat Schindler.

More importantly, because ASTS will operate on a wholesale basis, the EBITDA margin guided at ~90% is likely to be much higher than Kuiper’s, which will commercialize the fixed service on a retail basis and will thus be subject to distribution and marketing costs. In summary, we wouldn’t be surprised if both groups are exploring a larger agreement that could involve New Glenn’s support for BB2 launches and possible commercial/equity agreements between ASTS and Amazon in order to address the global satellite fixed-wireless opportunity."


Summary: Valuation arb: either SMR crashes 70% or GSRT closes the gap with nuclear SMR peers; one of two must happen.

structural marker; pre-classified as canonical yfinance ticker

@stepnotonpets Market will understand the greater arb soon enough. Either $SMR crashes 70% or $GSRT closes valuation gap w/ peers. One of the two has to happen.

If you're too lazy to read the presentation, and I know you morons hate doing the legwork, at least read this one from $GSRT presentation.

$OKLO $NNE $SMR $HOND. https://t.co/vlOjDdzzXh


Summary: Shares JPMorgan Overweight initiation on DKNG with $50 PT (~25% upside), long-term secular winner in digital gaming.

DRAFTKINGS $DKNG initiated at JPMorgan at 'Overweight' with a $50 price-target:

"Initiate at Overweight. Near-term, the setup appears mixed, as we see upside to 2Q estimates (favorable hold) but downside to FY26 estimates (tax hikes in Illinois, Louisiana, Maryland, etc.). Longer term, we view DKNG as a secular winner in the high growth Digital Gaming segment.

Similarly, we see a path back to $50/sh, implying ~25% upside potential from here. At current levels, DKNG trades at just 10x our FY27 adj. EBITDA estimate, which we note is 7% below the Street."


Initiate with Overweight rating and $45 price target. We see shares with a favorable risk / reward ratio.

Summary: Cantor Fitzgerald initiates BRZE at Overweight, $45 PT on undemanding valuation, strong growth levers, and improving operating margins.

BRAZE $BRZE initiated at 'Overweight' at Cantor Fitzgerald, with a $45 price-target:

"Initiate with Overweight rating and $45 price target. Our PT assumes an EV/rev multiple of 5.5x our CY26 revenue estimate. While BRZE is subject to macro headwinds, we view the current 4.3x EV/CY26E rev multiple as undemanding and likely already discounting a soft macro environment. As a result, we see shares with a favorable risk / reward ratio.

Ample growth levers to drive sustained strong growth: BRZE’s unique data platform and enterprise-grade technology positions the company well to capture its fair share of the ~$30b TAM. Upmarket traction has been, and will continue to be, a key driver of growth. BRZE continues investing heavily in its platform and expanding channel partner relationships, both key to driving further enterprise adoption. Cross-selling is an integral component of this algorithm. We think BRZE can maintain NRR north of 110% given the significant opportunities to sell into its base.

Driving significant operating leverage: Impressively, BRZE has driven robust incremental margins despite continued rapid growth; this should continue. We forecast op margins to reach 7.3% in FY27, or a ~1,600bps improvement from FY24."


It's the only stock in the world that is a pure play on uranium enrichment. Not selling one share

Summary: Holding LEU long; pure-play uranium enrichment with no intention to sell.

@JSpitTrades And not just technically. It’s the only stock in the world that is a pure play on uranium enrichment.

Not selling one share

Centrus Energy $LEU is the #1 nuclear name

Unreal strength. https://t.co/J3601nMc0w


Summary: Bullish SERV: stacked above MAs on all timeframes, strong volume profile, Uber Eats catalyst, 22% short float.

Serve Robotics $SERV stacked on top of moving averages on daily, weekly, and monthly. Rebounded perfectly off the daily 9/21 EMA stack at the lows today. Volume profile on the daily very strong. Coming off recent catalyst of Uber Eats partnership expansion. Float is 22% short. https://t.co/R186Z6ImCH


We view HOOD as a prime candidate for the S&P 500 with the next rebalancing... we would expect significant buying activity from passive funds (17% gross/12% net of their floats)

Summary: BofA views HOOD as prime S&P 500 addition candidate ahead of June 6 rebalance, expecting significant passive fund buying; ARES also possible addition, IBKR top migration candidate.

*ROBINHOOD $HOOD "PRIME CANDIDATE" FOR S&P-500 INCLUSION THIS FRIDAY, SAYS BANK OF AMERICA

"We hosted our quarterly update meeting with BofA’s Emma Huang on potential changes to the major indices across our Diversified Financials coverage in front of the next S&P rebalance (Friday/June 6 at 5:15pm). The announcement from S&P could include a combination of additions, removals, migrations, and share changes. Investors in our meeting were most focused on ARES, BAM, HOOD, IBKR, IVZ, LPLA and TW. HOOD/ARES possible additions; IBKR possible migration.

Following our meeting, we view HOOD as a prime candidate for the S&P 500 with the next rebalancing. We also view LNG, FLUT, VEEV, CVNA, ARES and APP as other top candidates for additions. We view IBKR as a top migration candidate from the S&P 400 due to its size, as well as the S&P 500 being underweight financials and the S&P 400 being overweight financials. Other top migration candidates include DUOL and EME. For HOOD or ARES, which aren’t a part of the S&P 400, we would expect significant buying activity from passive funds (17% gross/12% net of their floats)."


HOOD/ARES possible additions... We also view LNG, FLUT, VEEV, CVNA, ARES and APP as other top candidates for additions


We view IBKR as a top migration candidate from the S&P 400 due to its size


Summary: Bullish ASTS: high short interest combined with approach to all-time highs implies imminent short squeeze catalyst.

@spacanpanman How often do you see a stock approaching ATHs with 25% short interest


price-target raised to $25 (from $15) at BTIG... We reiterate our Buy rating.

Summary: Shares BTIG Buy reiteration on HUT 8 Mining with PT raised to $25 from $15 on HPC pivot and BTC treasury strategy.

HUT 8 MINING $HUT price-target raised to $25 (from $15) at BTIG:

"With HUT's American BTC subsidiary inching closer to their all-stock merger (expected to close this quarter) with Gryphon, the focus is now on securing HUT's first major HPC contract at their ~300 MW (~200 MW IT load) River Bend site in Louisiana. As a reminder, following the carve out, HUT now hosts ABTC's mining rigs and collects colocation, management and shared service (think back office functions) fees from ABTC.

This new structure should provide HUT a more predictable revenue stream while still providing some BTC mining exposure through their equity interest in ABTC. Next up, the focus (has been since last year) is on securing an HPC contract as management looks to secure more stable revenue streams. Additionally, HUT has identified ~2.6GW of potential power which has the potential to roughly triple HUT's power infrastructure footprint (think multi-year story).

And while HUT is no longer mining BTC, the company still holds roughly 10k BTC, which positions HUT as the ~10th largest BTC holder of US pubically listed companies. Bottom line: HUT should continue to benefit from a rising BTC price owing to its BTC treasury strategy and equity interest in ABTC, but is also looking to diversify its revenue stream with a pivot to HPC. We reiterate our Buy rating."


Summary: Still holding full LEU position from $96 re-entry with no plans to sell.

@ZenMinded1 Nothing wrong with locking in a win, but I haven't sold a single share since $96 re-entry and I don't plan to.

@stocktalkweekly Damn... I got out around 180. Don't see how far this can go on its own and LEU has failed me before. Congrats to holders.


Summary: BofA initiates LEU at Buy with $160 PT (~22% upside) on enriched uranium growth potential and planned LEU capacity expansion from 2029.

CENTRUS ENERGY $LEU initiated at Bank of America at 'Buy', with a $160 price-target.

Analyst Lawson Winder notes that Centrus is the world's only publicly-traded enriched uranium company:

"We initiate coverage on Centrus Energy (LEU) with a Buy-rating and $160 per share price objective (PO), implying ~22% upside. Centrus is the world’s only publicly-traded enriched nuclear fuel company at a time when the industry is poised for growth. It is a top distributor of low-enriched uranium nuclear fuel (also, LEU) in the U.S., the world’s largest nuclear power market.

It also operates a complementary technical solutions segment that includes a high-assay low-enriched uranium (HALEU) fuel business for next generation reactors, that could expand. Looking forward, Centrus plans to construct its own productive LEU capacity that we forecast starting-up in 2029, with a decade-long expansion thereafter. Our PO is based on 1.5x our estimated net asset value, a premium to nuclear fuel peers to account for potential unmodeled LEU (and/or HALEU) upside."


Summary: BofA reiterates Buy on AMD, raises PT to $200 on AI GPU/CPU upside and above-consensus Q2/Q3 estimates; INTC seen losing CPU share.

ADVANCED MICRO DEVICES $AMD price-target raised to $200 (from $175) at Bank of America ahead of next week's earnings:

"AMD reports Tuesday, Aug-5 after market close. Read-throughs point to: 1) potential (yet unconfirmed) China AI shipment resumption in 2H, ~$0.7-$1bn added to CY25 AI GPUs, ~$1.5-$2bn to CY26; 2) stronger than expected pricing for its current-gen MI355X ($20K+ vs. $17K cons); 3) continued strong demand for AI/GPU (cloud capex rising); 4) easier 2H PC unit comps, given AMD’s recent PC strength was mostly ASP driven rather than units; 5) while AMD 2H PC already well below seasonal by 1300bps/1400bps in Q3/Q4; and 6) healthy enterprise demand (HPE/TXN).

Overall, we expect upside to Q2/Q3 result/guide at $7.5bn+/$8.5bn+ sales (vs. cons. $7.4bn/$8.3bn) and CY25 sales/EPS toward $33bn+/$4.10+ (vs. cons. $32.2bn/$4.01). Longer-term, we expect AMD to reach >30% of overall CPU market by CY26, up from just <20% in CY23, as well as potentially 4-5% of AI GPU market.

Particularly, INTC’s prioritization of profitability and uncertainty re manufacturing offers greater opportunity for AMD to gain CPU share. Reit. Buy, raise PO to $200 from $175 prior, now on 36x CY26E PE from 31x, on stronger AI CPU/GPU environment, but still within historical 13x-39x."


Summary: Stifel initiates LEU at Buy with $220 PT on unique U.S. nuclear enrichment positioning, HALEU licensing, and multi-billion federal funding tailwinds.

CENTRUS ENERGY $LEU initiated at 'Buy' at Stifel, with a $220 price-target.

Analyst Stephen Gengaro says Centrus is uniquely positioned to build the U.S. nuclear supply chain:

"The atrophy of the U.S. nuclear supply chain is a key headwind for the resurgence in nuclear power in the U.S. market. With its long-time ties to the U.S. Government and as the only publicly-traded nuclear enrichment company, Centrus is uniquely positioned to play a critical role rebuilding the supply chain.

LEU has the footprint, technological expertise, and track record to source LEU for today's existing reactors, and buildout new enrichment to meet the more highly enriched uranium needs for new advanced nuclear reactors. We are initiating coverage on Centrus Energy (LEU) with a Buy rating and $220 target price based on our long-term DCF analysis.

KEY POINTS:

• Only Publicly Traded Enrichment Company: Born as a U.S. Government-owned business and privatized in 1998, Centrus is a long, established trusted partner of the U.S. Government and the only publicly traded enrichment company.

• Nuclear Power Growth: Faced with rising electricity demand, concerns about grid stability, and a push to reduce carbon emissions, nuclear power appears to be in the midst of a resurgence in the U.S. market. Nuclear has bipartisan support and the Government is helping fund the development of new small modular nuclear reactors (SMR) as well as helping build out the nuclear supply chain which has atrophied over the past 25 years.

• Imminent Structural SWU Supply Gap: The capacity to supply low enriched uranium (LEU), which is measured by SWU, is tightly held by a few players. This includes Russia, which faced a ban from the U.S. market in 2028, and accounts for roughly 40% of global SWU supply. This supply disruption will likely lead to rising prices, and we believe Centrus is well positioned to benefit longer term.

• Exclusive HALEU Licensing Advantage: Centrus holds the only NRC license for HALEU production in the U.S. and has already delivered enriched HALEU under its DOE contract -- placing it years ahead of potential competitors. HALEU is critical for fuel fabrication for the new generation of small modular nuclear reactors. • Early Commercial Momentum: Signed agreements with advanced reactor developers OKLO, TerraPower, X-Energy, and KHNP reflect rising demand for U.S.-based enrichment and HALEU, as the domestic nuclear ecosystem looks to de-risk fuel supply chains.

• Undervalued Optionality from U.S. Policy Headwinds: Multi-billion dollar federal funding push including $2.7 billion under the HALEU Availability Program and $2.2 billion requested for enrichment infrastructure. We believe Centrus likely captures out-sized government support as a strategically critical player in the U.S. path to reenter nuclear energy.

• A Story Stock: As the only publicly-traded enrichment company, Centrus has limited comps. Over the next 1-2 years, we believe the shares will fluctuate with data points around Government policy, demand for power including rising demand from data centers, and the timing of LEU's buildout. We note this is NOT a quarterly earnings story.

• Initiating with Buy a $220 Target Price: We are initiating coverage with a Buy rating and a $220 target price based on a long-term DCF analysis. We use 15x 2040 estimated EBITDA for a terminal value and a 12.5% discount rate."


Summary: Mizuho raises HOOD PT to $80 from $65, reiterates Outperform on $600B TAM and better-than-expected May metrics.

ROBINHOOD $HOOD price-target raised to $80 (from $65) at Mizuho, while maintaining a Outperform rating.

Analyst Dan Dolev says Robinhood deserves a bigger premium as it taps into a $600 billion TAM:

"Updating model & PT following solid May results. Better-than-expected monthly metrics are driving our 2Q25 revenue and adj. EBITDA estimates higher.

What are the upcoming catalysts? HOOD is hosting an event dubbed "To Catch a Token" on 6/30. We expect the event to feature major announcements regarding digital assets and their integration with traditional finance, and for discussion to have a particularly big focus on tokenizing real-world assets.

We believe HOOD deserves a premium to other fintechs given that [1] HOOD has proven its ability to grow rapidly and [2] it can tap into a $600bn TAM (currently <1%) with new products and geographies. PT to $80 from $65. Reiterate Outperform."


Summary: Confirms a long position in GENI.

industry='Internet Content & Information'

@stocktalkweekly $GENI is starting to get fun to follow. I just stated my DD on them and man it’s looking very promising!


Summary: Long SPHR: 30% short float, 200-day breakout on strong volume, plus Craig-Hallum Buy with $75 PT and long-term $200 target.

Sphere $SPHR float is 30% short and stock is confirming 200-day breakout on favorable volume profile @KevinLMak https://t.co/qPkSO5Lu4O

SPHERE $SPHR initiated at Craig-Hallum with a new Wall St.-high $75 price-target

Analyst Ryan Sigdahl says Sphere is disrupting the traditional venue model with original 'Sphere Studios' shows & advertising via 'Exosphere'. Craig-Hallum sees long-term upside to $200/share.


Summary: Long INDI as a high-short-interest catalyst play at the outset of a broader market rotation, up 40% and still has cushion if rotation is durable.

@1ChartMaster Paying attention to broader rotations like this & pairing it with high-short interest names with a catalyst, such as $INDI this morning, is how you quickly capture alpha at the outset of these rotations. Also gives you a horse with a cushion to ride if the rotation is durable.

---

@1ChartMaster $INDI 40% higher in a jiffy


Summary: TD Cowen upgrades CELH to Buy, PT raised to $55 from $37 on improving scanner trends, shelf space gains, and innovation pipeline.

CELSIUS $CELH upgraded to 'Buy' (from Hold) at TD Cowen, with a $55 price-target (from $37).

Analyst Robert Moskow says his opinion on Celsius' momentum has changed:

"When we downgraded CELH to Hold in January, we were concerned the brand had lost momentum and gone "ex-growth". Since then, Celsius scanner trends have improved to ~flat from the -HSD% sales decline seen in February. We expect to see continued improvement through the summer as comps ease from +35% in May to +19% in June and +11% in July.

We believe management has course-corrected execution on the Celsius brand with strong innovation (Retro Vibe, Playa Vibe, Strawberry Passionfruit), nationwide expansions for last year's retail exclusives (Watermelon Lemonade, Cherry Cola), and marketing efforts like the recent "Live Fit Go" campaign to expand the appeal of the brand beyond its core fitness-focused audience.

Additionally, mgmt recently said the core Celsius brand gained 15-20% more shelf space during spring resets (now largely complete). The energy category rebound more broadly has also provided a positive backdrop."


Summary: Shares B. Riley Buy rerate on SIMO, PT raised to $90 on Nvidia/Nintendo wins and PCIe/UFS share expansion lifting 2026-27 EPS.

SILICON MOTION $SIMO price-target raised to $90 (from $75) at B. Riley, while maintaining a 'Buy' rating:

"The deeper Nvidia (NVDA) Bluefield data processing unit win and Nintendo (NTDOY) Switch 2 consumer product cycle frames longer-term win implications for Silicon Motion.

This, plus on-track PCle Gen5 PC/notebook SAM and share expansion to 50%+ with 8- and 4-channel parts, plus similar from UFS 4.0 for smartphones, suggests the potential overall impact could lift calendar 2026 and 2027 EPS toward $5.25+ and $6.50+"


Summary: Shares JPMorgan upgrade of PINS to Overweight with $40 PT on user growth, monetization progress, and ad-spend capture via AI/Performance+.

PINTEREST $PINS upgraded to 'Overweight' (from Neutral) at JPMorgan, with a $40 price-target (from $35):

"We’re upgrading Pinterest to Overweight & raising our PT to $40. While PINS shares have outperformed YTD at +10% vs. the SPX +1%, they remain down -18% from the February market highs compared to the SPX more fully recovered at -3%.

We believe PINS has made solid progress across its 2023 Investor Day priorities to: 1) grow users & deepen engagement; 2) improve monetization/ARPU (mid-high teens revenue CAGR); & 3) drive profitable growth (30-34% adj. EBITDA margin target).

Importantly, we believe PINS is leveraging its full funnel ad approach and automation/AI capabilities — including Performance+ — to capture a greater share of ad spending among the next tranche of advertisers ($1B-$30B in sales), while some of the larger & more sophisticated advertisers already allocate 5-10% of their budgets to PINS."


Summary: Decisive bullish quality verdict on LEU.

Is MP and LEU the pain trades? #JaguarAnalytics @stocktalkweekly


Summary: Morgan Stanley raises CPNG PT to $32, makes it Top Pick on flywheel execution, tariff insulation, weaker USD tailwind, and attractive 23x EV/EBITDA valuation.

COUPANG $CPNG PT RAISED TO $32 AT MORGAN STANLEY

Coupang $CPNG price-target raised to $32 (from $27) at Morgan Stanley, while maintaining an 'Overweight' rating:

"We raise our PT to US$32 and make Coupang our new Top Pick. The company continues to execute well, is relatively insulated from tariff risk, and a beneficiary of a weaker USD. Valuations also look favorable compared to relevant peers.

No stopping the Product Commerce flywheel in Korea: Superior service driving traffic, which drives selection, scale, margins, and comes back in the form of benefits for consumers, continues to play out smoothly. Competitors have scrambled to respond, but Coupang's market share gains have continued without a blip. Despite the market uncertainties this year, we are quite comfortable Coupang can deliver on its growth targets, while also being a beneficiary of a weaker US dollar.

We are looking for 41% adj. EBITDA growth this year led by higher margins for Product Commerce: Rising tech spend had been a drag to margin expansion in 2024, but we have OG&A as percentage of revenues declining this year, which we see as a key underappreciated tailwind. We have Product Commerce margins expanding to 9% in 2025 (+150bps y/y), adding US$700mn to adjusted EBITDA, and more than offsetting our estimate for higher losses from Developing Offerings.

Valuations still look attractive to us at 23x EV/EBITDA for 2025e: Despite having risen 23% YTD, we still see valuations as attractive, with multiples expected to compress to 15x on our 2026 estimates. This implies to us that valuations are more favorable relative to relevant comps such as SEA which trades at 22x on 2026 estimates, and Mercado Libre which trades at 19x.

Taiwan not yet valued as SoTP for most investors: From our interaction with clients, Taiwan remains a potential catalyst which is yet to be valued as a separate entity. Despite management's commentary on increasing spend, Sensor Tower stats indicate very little change in terms of active users, and hence this remains a story which will require hard numbers to prove the strategy is working.

Raise PT by 19% to US$32: Our higher DCF-based fair value reflects primarily higher revenues for both Product Commerce and Developing Offerings (which incorporates weaker US dollar assumptions) as well as higher free cash flows for outer years coming to reflect slightly lower capital expenditure."


We initiate on Nebius (NBIS), a leading player in the AI Neocloud market, with a Buy rating and a 12-month price target of $68 implying c.45% upside

Summary: Goldman initiates NBIS at Buy, $68 PT (~45% upside), citing AI Neocloud growth, full-stack software edge, cost advantages, and inexpensive valuation vs peers.

NEBIUS $NBIS initiated at 'Buy' at Goldman Sachs, with a $68 price-target:

"We initiate on Nebius (NBIS), a leading player in the AI Neocloud market (a niche AI GPU infrastructure rental market), with a Buy rating and a 12-month price target of $68 implying c.45% upside (as of Thursday's close price of $46.4). Our rating reflects our positive view on the growth of the AI Neocloud market, as the Generative AI market continues to expand rapidly and AI startups/enterprises seek specialised capacity alongside that provided by hyperscalers.

While infrastructure provided by AI Neoclouds offers certain advantages over other GPU rental options, we see Nebius as especially well positioned in light of its full stack software offering, cost advantages and demonstrable expertise at scale. While we note the recent positive movement in the stock price, we see a positive risk-reward skew in our bull/bear scenario analysis.

Implied valuation of the AI infrastructure business is inexpensive vs peers, and we expect a supportive catalyst path over the next 12M to drive further outperformance."


Summary: Bullish ASTS: nine consecutive green days, impending golden cross, break above $40 opens new territory.

AST Spacemobile $ASTS now nine consecutive green days, four straight since I posted this chart last weekend. Golden cross (50 day over 200 day) impending on daily chart. Over $40 unlocks new territory. https://t.co/WWChI9f4Go

AST Spacemobile $ASTS potentially explosive consolidation on the weekly chart with a fantastic volume profile and high short-interest. https://t.co/p0RGH0oVQm


Summary: Long GENI: NFL ownership stake gives dual exposure to NFL growth + sports-betting duopoly, with potential SaaS re-rating as upside.

The NFL is Genius $GENI largest shareholder & now owns ~ 8.7% of the company, which means, you get exposure to both the growth of the NFL itself and a winner agnostic exposure to sports-betting.

The market potentially awarding Genius a SaaS multiple is just the cherry on top.

Ever wish the NFL was a publicly traded company? Me too. In my view, the closest way to get exposure to the NFL on the public markets currently is Genius Sports $GENI

Genius, for those unfamiliar, is a sports-betting data provider in an industry that is essentially a duopoly


Summary: Holding KTOS long with 2027 LEAPS; targets $100 on breakout from 25-year range with drone/autonomous weapons/hypersonic thematic tailwinds.

Kratos $KTOS breaking out of a 25-YEAR price range with highest-ever volume & extreme thematic relevancy (drones, autonomous weapons, hypersonic/supersonic engines).

I have been pounding table, stock is +80% YTD & my 2027 leaps are up +250%. Not selling any. Wake me up at $100. https://t.co/RIMnGoGPUu


Summary: Shares KeyBanc $112 PT on MTRN as undiscovered rare metals/Beryllium play; breaking key moving averages today.

industry='Other Industrial Metals & Mining'

$MTRN breaking over 200-day & pushing into 200-week & 50-month simultaneously today.

KeyBanc out this AM with $112 PT identifying it as an undiscovered name in U.S.-based rare metals as the Western hemisphere's only Beryllium player. Niche market, but strategically important.


Summary: Bullish CIFR breaking out above tight range while peers unwind, on record volume streak.

$CIFR non-stop... pushing above high & tight range today while other momentum stocks unwind...

Four straight days of 70M share, highest-ever volume on $CIFR, entire free float churned. Pretty unusual for a $1.8B market cap. https://t.co/gL0KzzcWvz


Summary: Shares Jefferies Buy initiation on Galaxy Digital, PT $35, on crypto regulatory tailwinds and AI data-center exposure.

GALAXY DIGITAL $GLXY initiated at 'Buy' at Jefferies, with a $35 price-target:

Analyst Jonathan Petersen calls it a dual-exposure to data-center theme and GENIUS Act with digital assets:

"GLXY is uniquely positioned to capture upside from a more favorable regulatory backdrop for crypto, and the growing demand for AI data centers. The CRWV lease at Helios was a transformational deal for GLXY, requiring a reconsideration of the value of that site.

Similarly, the passage of the GENIUS Act provides favorable market structure for GLXY's Digital Assets business, and re-rates its value. We initiate with a Buy rating and $35 PT."


Summary: Shares/endorses Guggenheim Buy reiteration on RBRK with PT raised to $105 from $80 on strong checks and ARR growth outlook.

RUBRIK $RBRK PT RAISED TO $105 AT GUGGENHEIM

Rubrik Inc. $RBRK price-target raised to $105 (from $80) at Guggenheim, while maintaining a Buy rating.

"Key Message: We believe RBRK is set up well to achieve consensus estimates for F1Q26 Subs ARR (though the beat may be less than usual) and revenue, while guiding above the Street for F2Q26, and modestly raising FY26 guidance for both key metrics. This is supported by our checks, that have remained positive since RBRK has been a public company.

Our checks indicate that RBRK is winning deals consistently, primarily due to their astute GTM strategy and differentiated solution set in security. We believe F1Q26 total revenue guidance is achievable with Total New ARR flat, including New Subs ARR growth of 4%, which is conservative, in our view.

We are modeling +16% Total New ARR growth and New Subs ARR +12% in our plausible case, which results in ample upside to consensus revenue, but less upside to Subs ARR than historically. Both FY26 Subscription ARR and revenue look achievable to us, and we believe the company could raise both key metrics, with room for further upside.

Our checks this quarter indicated that data protection will not be a casualty due to macro uncertainty, and that in a space experiencing secular tailwinds like this one is, it’s coming down to partner relationships and brand awareness that will determine who wins. Partners acknowledge RBRK as the best in both of these categories, and their unique integration of security into backup and recovery is being recognized by customers as the need for cyber recovery increases.

Of the partners we spoke with, two of the four exceeded their quarterly RBRK targets and one raised their full-year expectations, citing strength in their RBRK business regardless of the macro backdrop, while two were in line.

While RBRK may not be a cheap stock, trading at 14.4x NTM/ Rec Rev, we believe it may never be. We believe the company’s long-term trajectory as a leader in data protection, coupled with best-in-class New ARR growth, justifies this valuation. We remain Buy-rated and raise our PT to $105 from $80 due to raised out-year forecasts."


Summary: Roth/MKM initiates GENI at Buy, $16 PT, on 19%/36% rev/EBITDA CAGRs through 2028 and OSB tailwinds.

GENIUS SPORTS $GENI initiated at 'Buy' at Roth/MKM, with a $16 price-target:

"Initiating coverage with a Buy rating, $16 PT. We view Genius Sports as an attractive growth story with four-year estimated revenue and adjusted EBITDA CAGR's through 2028 of 19% and 36%, respectively, and a relatively consistent beat-and-raise track record.

Multiple tailwinds are arising from an expanding portfolio of sports data rights and services, most notably with healthy market growth from online sports betting (OSB), particularly with in-play, as well as with media services. Our $16 PT is based on 25x our 2026E adjusted EBITDA, a 30%+ discount to our multi-year growth outlook."


Summary: Holds NBIS as core long in the AI/HPC space, preferring it over mining stocks whose valuations have tripled.

@SpacBobby Chart looks great but I was very early to those mining stocks after the CORZ deal. Valuations are 3x what they were a couple months ago & most won’t get a contract. I made great money on that trade and not really looking back. $NBIS is my horse in that race and a core position.

@stocktalkweekly You should be in $HUT.  Next AI/HPC play to moon IMO


Summary: Shares BofA Buy initiation on AVAV with $300 PT; bullish on drone dominance, Switchblade differentiation, and market-share growth.

AEROVIRONMENT $AVAV initiated at 'Buy' at Bank of America, with a $300 price-target:

"While we see clear upside for AVAV from DoW “drone dominance” initiatives, we think the memo will likely spur increased competition from new and emerging commercial players. The memo encourages the DoW fast-track additions to the Defense Innovation Unit’s (DIU) Blue List (a list of commercial and bespoke DoW-approved UAS, components, and software). Though new competition is likely, we see AVAV’s technology suite, success of the Switchblade in Ukraine, and production capacity as key differentiators to maintaining and growing their market share."


Summary: Bullish PENN: ESPN app integration with ESPN Bet is a positive catalyst; stock re-testing 200-day is a technical setup.

$PENN there was a lots of speculation about if ESPN media would be integrated & leveraged into ESPN sports-betting operations. Today's story that the ESPN app will have redirecting links to the ESPN bet app is hard to spin as bearish for Penn. Stock is re-testing 200-day. https://t.co/8acAePAqjW


Summary: Bullish MTRN: undiscovered strategic rare metals/beryllium play at 1x sales vs peers at insane valuations; KeyBanc $112 PT, just breaking key MAs.

Not a soul was talking about this stock. Search the ticker. Stock is up +10% today post-earnings as market realizes it's a strategic rare metals play trading at 1x sales, while all rare metals peers trade at insane valuations. $MTRN

$MTRN breaking over 200-day & pushing into 200-week & 50-month simultaneously today.

KeyBanc out this AM with $112 PT identifying it as an undiscovered name in U.S.-based rare metals as the Western hemisphere's only Beryllium player. Niche market, but strategically important. https://t.co/778HLYgBUD


Summary: Recently accumulated GXO and AMKR as asymmetric risk-reward positions.

industry='Integrated Freight & Logistics'

@mvcinvesting $GXO $AMKR my two most recent adds. Check 'em out. Can search my tweets for my OG posts for a starting point if interested.

Which stock have you been accumulating most recently that you view as offering an asymmetric risk-reward profile?

Please, no more of the same 20 tickers over and over. Surprise me with something off the radar.


industry='Semiconductor Equipment & Materials'


Summary: Guggenheim raises GENI PT to $16 from $12; bullish on mid-to-long term outlook, secular sports betting tailwinds, and raised 2025 guidance.

GENIUS SPORTS $GENI price-target raised to $16 (from $12) at Guggenheim:

"GENI reported 2Q revenue and adj. EBITDA of $119mm and $34mm, respectively (in-line with our $120mm and $33mm forecast). Management raised 2025 guidance (details below), and expects GENI's business to be largely insulated from macro volatility this year. Based on their historical deal activity, we believe that the company remains open to M&A, and in lieu of any material M&A could be opportunistic on the buyback.

A number of recent announcements and the raised 2025 guidance give us added confidence in GENI's mid-to-long term outlook and execution. Our thesis remains unchanged - that Genius has built a scaled, differentiated global sport technology business well positioned to take advantage of secular sports betting tailwinds. PT moves to $16, up from $12."


Summary: Strongly bullish PLPC: rare combo of pure-play grid exposure, tiny float, profitable, cheap valuation, growing, tightly held.

It is *extremely* rare to get this combination $PLPC

1) Pure play on hot theme (the grid)
2) Extremely low float
3) Profitable
4) Reasonable valuation
5) Growing
6) Tightly held by insiders & institutions
7) Hot chart with strong volume profile

There's just simply not enough shares of $PLPC to go around...

2.5M share free float with 90% closely held (30% insiders, 60% institutions), profitable with 75% "pure play" exposure to grid + clean volume profile on the chart.

Growing at 1.6x sales, 23 P/E, holding net cash.


Summary: Author confirms long position in AMKR, aligning with EOY ATH thesis.

@Clutchcity_Ita @sam_badawi We'll see! I'm long AF

@stocktalkweekly @sam_badawi Thanx for the $Amkr hint

Going to ATH by eoy along with a chipmaker bullish run q4?


Summary: LEU and UUUU continue to outperform nuclear peers on down days, implying durable relative strength and bullish stance.

$LEU & $UUUU keep outperforming the other nuclear stocks on red days for exactly this reason...

The reason so many people missed obvious entries on $LEU & $UUUU is because they were too focused on the balance sheets & not focused enough on the assets (or the charts).

Yes, there's a lot of hype in nuclear right now, and the small modular reactor valuations are indeed


We are boosting our price target to $500, following a trip to China... TSLA remains our top idea for investing in autonomous vehicles and robotics.

Summary: Shares/adopts Piper Sandler Buy on TSLA, PT raised to $500; top pick for AV and robotics.

TESLA $TSLA price-target raised to $500 (from $400) at Piper Sandler.

Analyst Alexander Potter says he met with Chinese EV makers, and they acknowledged that they look to Tesla for guidance on real-world AI:

"We are boosting our price target to $500, following a trip to China. After meeting with Chinese EV makers, we can see why Elon Musk respects these “fast followers” so much. Indeed, vertically-integrated Chinese OEMs may be Tesla’s #1 competitive threat.

But when it comes to “real world” A.I., these companies look to Tesla for guidance – not the other way around. In the words of one company, “without Tesla going from 0 to 1, we can't go from 1 to 100.” Bottom line: TSLA remains our top idea for investing in autonomous vehicles and robotics."


Summary: Shares news of Palantir winning the largest DoD software award in history, a $10B/10-year Army contract; implied bullish.

*PALANTIR AWARDED HISTORIC $10 BILLION/10-YEAR DEAL TO PROVIDE SOFTWARE FRAMEWORK FOR THE UNITED STATES ARMY -- LARGEST DEPARTMENT OF DEFENSE SOFTWARE AWARD IN HISTORY $PLTR

---

Palantir's deal with the U.S. Army is not a traditional award, as it is a consolidation of 75 contracts across software & data, and provides the Army with volume discounts to purchase up to $10 billion of software from Palantir. The Army may or may not spend the full amount.


Summary: Kratos CEO says Golden Dome contract exposure will increase; positioned as hardware supplier across all major platforms and primes.

"We are already under contracts for projects related directly or tangentially with Golden Dome, and that's gonna increase. We are the hardware merchant supplier on radars, battle command systems, and interceptors for every prime for virtually every platform." - Kratos $KTOS CEO


we still think there's a lot more to play for, with an array of catalysts including major CTV partner ramps, potential remedies from the U.S. v. Google ad tech trial... We maintain our Outperform rating and raise our price target to $27 from $19 prior

Summary: Evercore ISI reiterates Outperform on MGNI, raises PT to $27 from $19 on CTV ramps, Google ad-tech remedies, and FY27 growth outlook.

MAGNITE $MGNI price-target raised to $27.25 (from $19) at Evercore ISI:

"Our View: MGNI reported a solid Q2 despite intraquarter macro uncertainty, guided Q3 above the Street, and reinstated FY25 guidance, with a consistent growth outlook and slightly higher margin expansion outlook vs. prior view. While the stock has been up nearly 40% YTD (vs. NASDAQ up 10%), we still think there’s a lot more to play for, with an array of catalysts including major CTV partner ramps, potential remedies from the U.S. v. Google ad tech trial, a potential damages award related to Google’s monopolistic conduct, DV+ wins, growth in curation and supply-side decisioning, the emerging SMB CTV opportunity, etc. We maintain our Outperform rating and raise our price target to $27 from $19 prior as we roll our valuation framework forward to FY27."


Summary: Shares Roth/MKM Buy initiation on GrabAGun with $8.25 PT on market share gains and consolidation opportunity.

GRAB-A-GUN $PEW initiated at 'Buy' at Roth/MKM, with an $8.25 price-target:

"We are initiating coverage on GrabAGun (NYSE: PEW) with a Buy rating and $8.25 PT. We expect the newly public company to take share in the fragmented and large shooting sports market, outgrowing soft industry trends as brand awareness builds and secular trends of online purchasing in the firearms market take hold. We also think the shooting sports industry is ripe for consolidation after a multi-year period of softness post-COVID, which presents significant opportunity for GrabAGun, with a large cash war chest (~$4/share)."


Summary: Shares Needham's Buy reiteration on SLDP with PT raised to $4 on solid-state battery progress and increased ASSB share assumptions.

SOLID POWER $SLDP price-target raised to $4 (from $2) at Needham:

"We reiterate our Buy rating and raise our target to $4 post 2Q results and commentary. Our high level thesis remains unchanged, with SLDP and peers benefiting from increased all-solid state battery enthusiasm, with SLDP's cell and electrolyte partnerships both showing consistent progress, increasing the call option value inherent in SLDP's shares given the sizeable cash balance vs burn rate, allowing SLDP to weather the downturn in US EV adoption front and center on US investors minds. Our updated $4 target is 5x our '32E adj EBITDA discounted back and assumes a 4.5% ASSB share of EV units, up from 4% prior, and ~$500 of monetization per vehicle. We model SLDP raising $200M in FY27."


Amkor $AMKR is part of Apple's re-shoring plan. And the stock trades 1x sales? 😂

Summary: Bullish AMKR: Apple re-shoring endorsement from Tim Cook + 1x sales valuation seen as cheap.

From Tim Cook’s mouth: Amkor $AMKR is part of Apple’s re-shoring plan.

And the stock trades 1x sales? 😂

 https://t.co/vBr8YjylNw


Summary: Shares UBS upgrade of PTON to Buy, PT $11 (from $7.50), on FY26 EBITDA upside, improving data, and undemanding valuation at ~6-7x EBITDA.

PELOTON $PTON upgraded to 'Buy' (from Neutral) at UBS, with an $11 price-target (from $7.50):

"We are upgrading PTON to Buy from Neutral with PT of $11, implying near doubling of the stock from current levels. Our more positive view is driven by: 1) upside to FY'26E EBITDA expectations from top line growth and further cost cutting; 2) improvement in underlying data we have been watching for PTON; 3) favorable risk/reward and undemanding valuation that implies the stock is trading at ~6-7x EBITDA when cash flows are inflecting.

We believe PTON's FY'26 EBITDA guide could come in above expectations, despite an uptick in marketing spend, driven by revenue growth supported by price increases in subscription business and measured churn increase, as well as further opex optimization beyond current cost-cutting plans. Our math suggests PTON could guide FY'26 EBITDA closer to $400-$450M range, despite double digit increase % in marketing spend. This is nicely above Street's $358M expectation."


Summary: Bullish AMKR as the key beneficiary of TSMC/Apple using US-based packaging to placate tariff pressure, trading under 1x sales.

Put yourself in Taiwan Semi or Apple's shoes.

You want to placate the President & avoid tariffs. He wants chips made in America now, but you know that moving fabrication here will take years.

What's the easiest way to appease? Use a U.S.-based OSAT for packaging... $AMKR

Amkor $AMKR

- Broadcom $AVGO is designing OpenAI chips
- Amkor won 2024 'Best Supplier Award' from Broadcom
- Amkor partnered with Taiwan Semi $TSM & Apple $AAPL to launch largest OSAT hub in the U.S. -- Apple to be first customer
- Trades under 1x sales
- Testing 200-week SMA https://t.co/1UqCCaTAOp


Summary: Bullish on AMKR and GXO as undervalued gems in hot themes, trading at 1x and 0.5x sales respectively with growth.

@pennycheck People think everything in this market is super expensive and extended.

Untrue.

Just a couple weeks ago, stumbled upon $AMKR trading at 1x sales. Now, $GXO trading at 0.5x sales (and profitable) with double digit growth.

There are gems in hot themes that are still unfound.

@stocktalkweekly amazing find
goes to show what you can uncover when you dig a bit under the hood


$GXO trading at 0.5x sales (and profitable) with double digit growth


Summary: Bullish DPRO: lean float, record volume, peers at 10-20x valuation, catalysts ahead; targets $12.50 on break above $7.75.

@BlackScholesMan - Lean 18m share float, small $6 pps
- Highest-volume-ever pushing price above 100-week moving average for first time ever
- Peers trading at 10-20x the valuation
- Catalysts on deck

Over $7.75 sends to $12.50 IMHO

@stocktalkweekly Lot of shorts trapped in $DPRO with a high borrow fee


Summary: Wells Fargo upgrades AMZN to Overweight, PT $280, on AWS acceleration driven by Project Rainier/Anthropic; author shares/adopts the thesis.

AMAZON $AMZN upgraded to 'Overweight' at Wells Fargo with a $280 price-target (from $245), citing that Anthropic could lead to AWS acceleration:

"Upgrading AMZN to OW (from EW) on greater conviction in AWS acceleration in '26. Raising AWS growth to +22% from prior/consensus of +19%/+18%. We see Project Rainier, a significant compute capacity build w/ partner Anthropic, as the primary driver of acceleration, contributing 5%/4% to AWS growth in '26/'27.

We view AWS revenue acceleration as the key to the reversal of share underperformance YTD (flat vs. NDQ +17%). Increasing our 2026 / 2027 AWS revenue estimates by 3% / 7% as we see Project Rainier capacity additions starting in early 2026 supporting incremental Anthropic compute.

Expect Project Rainier Phase 1 (1.3GW) to come online in Jan '26 w/ 6-month utilization ramp and Phase 2 to start coming online in 4Q26. We estimate Indiana campus at full capacity (2.2GW) contributes ~$14B annual revenues to AWS. We forecast Anthropic contributes 7 points to AWS 2026 revenue growth (vs 3 points in 2025).

See AWS market share losses peaking in 2025 (-470bps y/y), improving in 2026 and beyond as AWS accelerates, alleviating competitive concerns. While share losses remain material, we take solace in stronger industry growth and rising AWS estimates. Project AWS share losses modestly improve to -420bps y/y in 2026, -260bps y/y in 2027 and -180bps y/y in 2028. By 2029, see AWS at 32% share, down from 47% in 2024. However, over that period, see cloud industry 31% CAGR to $870B from $230B in 2024.

Risks to our call include execution of scaling Project Rainier, performance of Trainium chips, further deceleration of core (non-AI) workloads, and greater AI-related margin headwinds than anticipated. See operational execution of Project Rainier (and data center capacity more broadly) as key risk given ongoing supply constraints and uncertainty around large Trainium deployments. We assume AWS OI margin compression of 270bps / 180bps y/y in 2026 / 2027 tied to scaling AI deployments."


Summary: TikTok deal approval is bullish for Oracle as the likely tech infrastructure partner.

*CHINA AGREES TO TERMS OF U.S. TIKTOK DEAL $ORCL


Summary: Long UUUU; owns it in anticipation of an MP Materials-style government deal.

@JustBill1182 I agree that’s why I own it

@stocktalkweekly I think $UUUU getting an MP style deal is not out if the question


Summary: RBC upgrades JMIA to Outperform with PT raised to $15 from $6.50 on easing FX pressures enabling supply expansion and order growth.

JUMIA $JMIA upgraded to 'Outperform' (from Sector Perform) at RBC Capital, with a $15 price-target (from $6.50):

"We hosted JMIA’s CEO and CFO for virtual investor meetings and come away incrementally positive, particularly on the sustained supply benefits the company is getting from easing FX pressures. We've underappreciated the magnitude of the headwinds the company faced last year due to currency volatility and thus, anything approaching stability from here could allow for further supply expansion, order growth acceleration and upside in the shares. As such, we raise our estimates slightly, upgrade to Outperform and raise our price target to $15 based on 6.8x EV/'26E revenue (prior $6.50 PT based on 2.7x EV/'26E revenue) where our estimates could still prove conservative."


$LYFT red to green as market realizes company is growing revenue double digits while trading at less than 1x sales and less than 5x free cash flow…

Summary: Bullish LYFT: double-digit revenue growth trading below 1x sales and 5x FCF makes it deeply undervalued.


Summary: Bullish AMKR; groundbreaking of Arizona campus signals inflection point ahead.

Amkor has officially broken ground on our new advanced semiconductor packaging & test campus in Arizona—the first of its kind in the U.S. Backed by CHIPS for America + partners like Apple, NVIDIA & TSMC, we're boosting the U.S. chip supply chain.

🔗 https://t.co/hUlvocngwL $amkr https://t.co/vWXu4TiwZE


There's just simply not enough shares of $PLPC to go around... 2.5M share free float with 90% closely held, profitable with 75% "pure play" exposure to grid + clean volume profile on the chart. Growing at 1.6x sales, 23 P/E, holding net cash.

Summary: Bullish PLPC: tiny 2.5M float, 90% closely held, profitable grid-exposure play at 23x P/E with net cash.

There's just simply not enough shares of $PLPC to go around...

2.5M share free float with 90% closely held (30% insiders, 60% institutions), profitable with 75% "pure play" exposure to grid + clean volume profile on the chart.

Growing at 1.6x sales, 23 P/E, holding net cash.


Summary: Cantor Fitzgerald initiates USAR at Overweight, $16 PT, as uniquely positioned domestic heavy rare earth supplier amid global trade tensions.

USA RARE EARTH $USAR initiated at 'Overweight' at Cantor Fitzgerald, with a $16 price-target:

"We are initiating coverage of USA Rare Earth (USAR) with an Overweight rating and 12-month price target of $16. Global trade tensions have sparked new supply chain risks to rare earths that enable high-tech industries (semiconductor, renewable energy, robotics) and defense applications.

Specifically, the supply chain for 'heavy' rare earths, a supply chain for which ~90% of refining and magnet manufacturing resides in China, has been a key point of leverage in trade talks. We believe USAR is uniquely positioned to establish a fully-integrated, domestic supply chain for 'heavy' rare earths and will be a key beneficiary from customers whose manufacturing relies on rare earths."


Lyft (LYFT: Buy, PT from $20 to $26) ... Lyft remains one of our best ideas

Summary: Benchmark raises LYFT PT to $26, reiterates Buy as best idea on AV partnerships and EBITDA upside; UBER rated Hold.

LYFT $LYFT price-target raised to $26 (from $20) at Benchmark.

Analyst Daniel L. Kurnos says "do not exit the vehicle while it is in motion":

"In what some considered a long overdue announcement (and which others suspected would never come), Lyft (LYFT: Buy, PT from $20 to $26) furthered their credibility in the rideshare space with their first Waymo partnership last week, breaking Uber’s (UBER: Hold) perceived stranglehold, along with the thesis that Lyft was just not part of the serious AV conversation.

We have lost track of how long we have been saying that the realities on the ground do not match up to investor expectations, even with the Companies themselves offering a more level-headed outlook. We do, however, think that a good portion of the thesis we built our January upgrade and subsequent best idea call around has played out, which begs the question – what now? It feels hard to argue with the execution thus far, but, even as optimistic as we remain regarding the Company’s future prospects, we are still well short of Lyft’s 2027 targets, despite being ~$55 million above the street on EBITDA.

Furthermore, we are not sure that the street is factoring in all the components of the recent slew of announcements, although CFO Erin Brewer has done her best to try and spell some of it out. That said, our bet remains that, come 2027, Lyft gets closer to $1 billion in EBITDA than the street’s $830 million, which suggests that shares still look very attractive from a valuation perspective.

How we get there, however, could very well be a bumpy ride, so buckle up but please do not exit the vehicle while it is still in motion; Lyft remains one of our best ideas."


Summary: Decisive bullish stance on EOSE.

@400kProject I try to focus on under-discussed names on this page. I like $EOSE though 🙏


Summary: BofA initiates OKLO at Buy with $92 PT on IPP economics, >60% EBITDA margins at scale, and above-consensus 2033E estimates.

OKLO ENERGY $OKLO initiated at 'Buy' at Bank of America, with a $92 price-target:

"Oklo’s build-own-operate model is more capital intensive than peers, but by taking balance-sheet risk the company can deliver fully wrapped, bankable PPAs and capture the full IPP economics. We estimate its first-of-a-kind 75 MW projects (the initial units, which are typically costlier and less efficient) at ~13% unlevered IRRs (~2.5x cost multiple).

By contrast, nth-of-a-kind units (later deployments that benefit from design repetition, supply chain scale, and lower costs) could achieve ~26% IRRs (~6x multiple).

At scale, this supports >60% EBITDA margins (well ahead of peers at mid-teen margins). We base our $92 PO on an 80/20 blend of peer multiples and DCF methodology, consistent with our NuScale approach.

We apply 14.1x & 11.1x on 2032/2033E EV/EBITDA and a 15.5% discount rate in our DCF. On our above-consensus estimates (~$1.5B for 2033E on 1.1GW on deployments p.a.), the stock trades at 6.6x EV/EBITDA, below SMR developer & fuel suppliers (12.1x), implied IPPs (7.0x) & datacenter peers (14.2x). Risks: licensing delays, slower PPA conversions, HALEU supply, and execution."


Huntington Ingalls $HII another one of my portfolio names that no one talks about... 16 out of the last 18 weeks green... this remains the best pure-play out there

Summary: Long HII as best pure-play on shipbuilding; held position boosted by $33.8B defense reconciliation package.

Huntington Ingalls $HII another one of my portfolio names that no one talks about...

16 out of the last 18 weeks green...

Trump sure did a lot of talking about shipbuilding today & this remains the best pure-play out there... https://t.co/oa113jeNjW

Out of the $33.8 billion allocated to Shipbuilding in the $150 billion Republican Reconciliation Package, $20.3 billion is being allocated for 16 specific ships.

Those ships are:

- Two Flight III Arleigh Burke guided missile destroyers ($5.4 billion)
- One Block VI


Summary: Holds NBIS as a high-conviction portfolio position.

Our members win big consistently, because I share my full portfolio along with weightings, so you know exactly where my conviction is, like with Nebius $NBIS https://t.co/2atZiUI8Wk


How often does the U.S. Secretary of Commerce personally attend the signing of MOUs for $3 billion companies? $LEU

Summary: Bullish LEU: Secretary of Commerce attending the MOU signing signals unusual high-level government backing for this small-cap.

*CENTRUS ENERGY $LEU SIGNS MOU WITH KOREA HYDRO & NUCLEAR POWER $KEP AND POSCO INTERNATIONAL TO EXPAND CENTRUS' URANIUM ENRICHMENT PLANT IN OHIO

Centrus Energy today signed a Memorandum of Understanding (MOU) with Korea Hydro & Nuclear Power (KHNP) and POSCO International to


Summary: Long GXO as undervalued automation/robotics play at 0.5x sales with multiple-expansion potential as growth accelerates.

GXO Logistics $GXO - An undercover robotics/automation stock

- GXO Logistics is a contract logistics, automation & warehousing company

- Stock trades at just 0.5x sales while doing $12.7 billion in TTM revenue (up +22%) at a $5.9 billion market cap

- GXO designs, builds, and operates automated, robotics-enabled warehouses & value-added logistics for blue-chip global brands like Apple, Boeing, Nike, Nestlé & Whirlpool

- GXO purchases robotics hardware from partners (Locus AMRs, AutoStore cube systems, Geek+ robots) and integrates them with proprietary software like WMS (Blue Yonder, Manhattan), and then deploys those integrated systems on behalf of their blue-chip customers

- Accelerating convenience trends like grocery delivery (and the e-commerce runway broadly) are tailwinds for warehousing volume & optimization of those warehouses

- Warehouse automation is likely to be one of the first areas of mass-penetration for robotics, as commercial players have both the immediate incentive & necessary capital to implement these systems rapidly

- GXO benefits directly from increased adoption of automation & robotics, without the necessary multi-billion dollar capital investment to build these products at scale

- GXO has room for significant multiple expansion as the company returns to consistent double-digit growth, and becomes theme-associated as an exposure to automation/robotics


Summary: Bullish FUBO on cheap valuation (1x sales) and pending Disney merger catalyst.

@MinervaCap Clean look, trading 1x sales, Disney merger on the horizon... I like the odds

Picked up $FUBO on the post-ER dip today, thanks @stocktalkweekly! https://t.co/vgCEIgtsoG


Summary: Still bullish HOOD; endorses parent's view that the trade remains obvious.

@stocktalkweekly $HOOD was such an obvious one! Missed out 🤦🏾♂


Summary: Bullish UiPath: business inflecting and chart setup compelling.

@donOasis1 Yes, I commented on it in another reply. Biz is inflecting and chart is very very nice.

@stocktalkweekly Path:
The company is expanding its capabilities via collaborations with Snowflake, OpenAI, NVIDIA, and Google, positioning itself at the forefront of automation combined with advanced AI.

For Q2 FY2026 (ended July 2025), UiPath reported revenue of $362 million.


Summary: AMKR named as the single best way to play US semiconductor reshoring.

@EricTheUmpire At this point , probably the single best way to play U.S. semiconductor reshoring

@stocktalkweekly All the chip news this morning seems good for $AMKR


Summary: Cantor Fitzgerald upgrades AMTM to Overweight, PT $35, on Space/Nuclear catalysts and de-risked efficiency concerns; views weakness as a buying opportunity.

AMENTUM $AMTM upgraded to 'Overweight' (from 'Neutral') at Cantor Fitzgerald, with a $35 price-target (from $25):

"We are upgrading AMTM to OW from N and increasing our PT to $35 from $25 per share on both valuation and looming Space/Nuclear catalysts.

While initially a robust performer post 2024 IPO (+30% Sep 22 to Nov 4, vs. S&P500 down 1%), we think AMTM shares have languished due to a mix of government efficiency concerns and shareholder concentration overhang. On efficiency dynamics, we believe the bulk of concerns have been de-risked with AMTM’s SLS program funded through 2030 by FY25’s BBB Bill and Congress/investors alike appreciating the necessity of AMTM’s nuclear work (misconstrued as true "environmental" work).

In terms of shareholder concentration (~35% insider ownership), we view cap table problems as transient, not structural, with investors essentially timing ~2-3 "trades" over the course of private equity’s sale process before unlocking significant upside. So, what does that mean near term? We view any potential weakness as an opportunity for investors to get more of what is arguably our coverage’s most undervalued asset."


Summary: Initiated long Photronics PLAB; paired with existing long AMKR in semi supply-chain re-shoring basket.

I was not going to share this on X, but since I discussed on Spaces, the stock we initiated yesterday was Photronics $PLAB

It will be paired in my semi supply chain re-shoring basket with core position $AMKR (initiated @ $24.35 on Sept. 5, search 'from:@stocktalkweekly $AMKR')

New portfolio position initiated in semiconductor mid-cap stock at https://t.co/NbEwQ50fBf


paired in my semi supply chain re-shoring basket with core position $AMKR


Summary: Shares JPMorgan upgrade of UPST to Overweight, $88 PT; best risk/reward among personal loan originators vs Neutral-rated SoFi and LendingClub.

UPSTART $UPST upgraded to 'Overweight' (from Neutral) at JPMorgan, with an $88 price-target:

"We lean positive on the more seasoned fintech lenders, given a favorable macro backdrop (e.g., stable credit and potential rate cuts), and we believe Upstart offers the best risk/reward among personal loan originators (e.g., Neutral-rated SoFi and LendingClub). UPST shares have underperformed year to date, declining ~20% since reporting 2Q results, primarily on concerns around balance sheet growth and a new convertible issuance, despite positive YTD revenue and adj. EBITDA revisions (Street ‘26 estimates up 37% and 87% YTD, respectively).

Loan buyer demand remains strong, and we see opportunity for continued notional loan growth and margin expansion. Our $88 Dec. ‘26 price target (~35% upside from current levels) applies a 6.5x P/Sales multiple to our ‘27 estimates, representing a half-turn premium to its TTM average, which feels fair in light of the improving macro backdrop and margin profile."


Summary: Concedes fundamentals aren't compelling but chart remains very bullish; expects price to go higher.

@RJTradez I know the business. Not compelling to me. But, chart is very bullish still so prob goes higher.

@stocktalkweekly @stocktalkweekly $SOUN is my pick, AI solutions for automotive, IoT, and customer service industries, with a market cap around $6B. Their Houndify platform and Smart Answering tools are gaining traction, offering APIs and real-time data integration that boost conversational AI


Summary: Bullish GXO on imminent first-ever 200-week MA breakout confirmation.

$GXO looking to confirm first-ever 200-week breakout this week https://t.co/9FU9Wv6WCN

GXO Logistics $GXO - An undercover robotics/automation stock

- GXO Logistics is a contract logistics, automation & warehousing company

- Stock trades at just 0.5x sales while doing $12.7 billion in TTM revenue (up +22%) at a $5.9 billion market cap

- GXO designs, builds, and https://t.co/3MScqFm5xa


Summary: Bullish AMKR: author calls it mispriced, endorsing the Broadcom/TSMC/Apple catalyst thesis at under 1x sales.


Summary: Shares Piper Sandler's raised PT $28 (from $20) and Overweight reiteration on LYFT; Waymo deal validates AV strategy, compelling valuation at ~10x 2027E FCF.

LYFT $LYFT price-target raised to $28 (from $20) at Piper Sandler

Analyst Thomas Champion says the Waymo deal is a major validation of their autonomous strategy:

"Waymo Validates AV Strategy; Yesterday, Lyft announced a partnership with Google's Waymo to provide full fleet management for a Nashville AV roll-out in 2026. The announcement adds to multiple other partners including May Mobility, Mobileye, and Baidu. The Waymo deal provides more validity to Lyft's right to win in the AV ecosystem.

We're updating our model and raising estimates to reflect greater contribution from FREENOW and recent management commentary. FY26E revenue moves +1% while EBITDA moves +6%. PT to $28 from $20.

Management appears to be executing well in the early innings of an AV transition. Pricing pressures that emerged in late '24 / early '25 appear to have moderated. That said, we think valuation is still compelling despite the recent move in the stock: on our updated numbers, LYFT trades at ~10x 2027E FCF per share. PT to $28 from $20. Reiterate OW."


Summary: Needham raises ANET PT to $160 on AI ecosystem wins, Anthropic supply deal, and enterprise campus expansion.

ARISTA NETWORKS $ANET price-target raised to $160 at Needham:

"At its Analyst Day Arista management laid out of a compelling vision for the continued transformation of the company, outlining new Cloud/AI capabilities targeting both White Box and Nvidia, and new investments in Enterprise Campus which take direct aim at Cisco.

We also gained strong appreciation for key new senior management hires whom we see as capable of driving the rate of change necessary to expand the company's dominant lanes.

Among its new AI ecosystem partners, our proprietary checks confirm that Arista became a major new supplier to Anthropic in 2025 whom we expect to contribute material Revenue in 2026. We adjust our F26 estimates modestly, and we increase our PT to $160."


Summary: OpenAI's $1T AI infrastructure buildout in partnership with NVDA and ORCL is bullish for both named partners.

*OPENAI TO SPEND $1 TRILLION ON AI INFRASTRUCTURE ACROSS THE UNITED STATES & ABROAD IN PARTNERSHIP WITH NVIDIA AND ORACLE - WALL STREET JOURNAL $NVDA $ORCL

OpenAI laid out its vision for a vast, $1 trillion build-out of computing warehouses across the U.S. and abroad today, showcasing a Central Park-sized complex about 180 miles west of Dallas.

OpenAI disclosed that it would ultimately need more than 13 times the computing power of its first nascent site.


Summary: B.Riley initiates ADTN at Buy, $16 PT, on telecom recovery, access+optical cross-sell, Huawei share gain, and balance sheet improvement.

ADTRAN $ADTN initiated at 'Buy' at B.Riley, with a $16 price-target:

"ADTN is a leading provider of broadband network equipment, serving a diverse customer base including service providers, utilities, and municipalities. In July 2022, it acquired optical networking equipment supplier ADVA, which doubled ADTN’s TAM from $7B to $14B. While the comm equipment industry went through an inventory correction cycle in 2023–2024, the latest industry data indicate that demand has recovered, and we believe ADTN is positioned to capitalize on the current cycle with its access and optical businesses. Demand in Europe, a significant market for the company, is particularly strong.

We expect ADTN, as one of only a few companies offering both access and optical solutions, to gain market share through cross-selling initiatives. Furthermore, as European service providers pivot away from Huawei, ADTN is well positioned to capture market share as one of few turnkey comm equipment suppliers. ADTN is benefiting from the telecom industry recovery, with incremental growth driven by market share gain opportunities.

ADTN plans to strengthen its balance sheet via the sale of certain real estate and its Timing/Synchronization business. This, coupled with improving profitability, will likely give ADTN more flexibility in its effort to retire minority share liability, which we believe has been a minor overhang on shares."


Summary: Endorses bullish GENI setup: MA crossovers above 200-week, record volume, gap fill upside.

$GENI doesn't get prettier than this. All moving averages simultaneously crossing 200-week (including 50/200 golden cross). Highest daily, weekly, and monthly volume ever. Climbing into a big gap to the upside. https://t.co/ugpkUAs8dh


Summary: Endorses KTOS breakout thesis from quoted tweet; bullish on drones/autonomous weapons/hypersonic play targeting $100.

Kratos $KTOS breaking out of a 25-YEAR price range with highest-ever volume & extreme thematic relevancy (drones, autonomous weapons, hypersonic/supersonic engines).

I have been pounding table, stock is +80% YTD & my 2027 leaps are up +250%. Not selling any. Wake me up at $100. https://t.co/RIMnGoGPUu


Summary: Bullish PATH on improving chart + real business development; potential bottom forming.

$SNAP is below every moving average on the monthly chart and has been a general shit earnings performer. What on earth would incline you to think there aren't better opportunities for your money elsewhere

$PATH chart looks sick and looks like they're finally building a real biz. Genuine shot at a bottom event down here

@stocktalkweekly $SNAP the volume has been unreal recently. FCF trending higher while stock price has not budged. Improving fundamentals and users climbing as well. Or $PATH technically looks good, lots of partnerships announced recently, and improving fundamentals. Thoughts?


Summary: JPMorgan reiterates Overweight on Sea Ltd, raises PT to $230 from $208 on Shopee monetization step-change and fintech upside.

SEA LTD. $SE price-target raised to $230 (from $208) at JPMorgan, while maintaining an Overweight rating.

"The step-change in ecommerce industry monetization should allow Shopee to further enhance monetization, recycle the revenues to support growth investments, unlock ad revenues, benefit from reduction in logistics costs, and drive higher customer engagement.

We illustrate this below using our FY25E forecasts as a base to understand the financial impact. What is not captured in the quantitative calculations is the widening competitive moat through better customer experience (service + costs) and ecosystem informational advantage.

The latter supports SE’s fintech business as well. We reiterate OW on SE and raise our Jun-26 PT to $230. One key known unknown is how SE would deploy its growing cash position alongside rising cash flows."


Summary: Goldman initiates UEC at Buy, $13 PT (~30% upside), on US uranium dominance, no debt, and nuclear demand growth.

URANIUM ENERGY CORP $UEC initiated at 'Buy' at Goldman Sachs, with a $13 price-target:

"We initiate coverage of Uranium Energy Corp (UEC) with a Buy rating with ~30% implied upside to our 12-month price target of $13. UEC is a pure-play, US-based uranium mining company that is currently advancing a broad portfolio of assets that has the capability to ramp to several million pounds of production capacity over the medium term.

The company also has the largest licensed processing capacity within the US, has no debt, and remains levered to potentially higher pricing (our view) within the nuclear fuel supply chain (in particular, for triuranium octoxide (U3O8)). With nuclear energy demand poised to experience significant growth in the US, we view UEC's domestic position as key competitive advantage with the potential to drive scarcity value in an environment where policy support and potential investment into critical minerals across key industries, such as nuclear, are gaining momentum and driving structural market shifts."


Summary: Bullish AMKR: leading domestic OSAT with TSMC/AAPL/AVGO partnerships deserves 1.5–2x sales vs current sub-1x.

$AMKR do you think it would be unreasonable for the leading domestic OSAT play, with pen-on-paper partnerships with Taiwan Semi $TSM Apple $AAPL and Broadcom $AVGO, to trade at 1.5x or 2x sales in this environment?

I don't.


Summary: Long AMKR: positioned to win business from TSM/Apple/Broadcom AI chips + market will re-rate on upcoming capacity expansion.

@hiteshkar $AMKR is in prime position to gain material business from TSM, Apple, and Broadcom's growing AI-chip offering. There is also a massive capacity expansion on the horizon which the market will likely look ahead to.

@stocktalkweekly Mr. Market just sees stalling growth and lower margins.
But the balance sheet grows and there is cashflow.

Will Apple be a significant growth driver for AMKR? https://t.co/9FcCdNpZLc


Summary: Bullish DOCN: above 200-week MA for first time ever, 200-day breakout confirmed, strong weekly candle forming.

$DOCN putting in the beginnings of a very nicely weekly candle, now above 200-week for first time ever, and 200-day breakout confirmed last week. https://t.co/0Y0g7Y3aeY

$DOCN one hell of a monthly chart. August HVE trying to put in a bottom. Daily also pushing above 200SMA. https://t.co/o23Ye8HnUU


Summary: Rosenblatt raises MU PT to $250 (new Wall St. high) on HBM leadership, margin expansion, and supply-constrained up-cycle through FY26.

MICRON $MU price-target raised to new Wall St. high of $250 at Rosenblatt:

"Micron exceeded its upwardly revised estimates for the August quarter and issued strong November guidance, projecting 10.5% sequential revenue growth and a 51.5% Non-GAAP gross margin, both well above consensus. Gross margin improvement is from the old fashion method: selling higher-margin products, raising prices, and reducing costs.

We believe this trend will continue through FY26 as constrained wafer supply struggles to meet rising demand across all end markets. What stands out most is Micron’s progress in HBM, including reported HBM3E leadership, expected HBM4 performance advantages, and the potential for customized HBM4E solutions. These innovations could extend the current up-cycle beyond historical precedents. Accordingly, we are raising our estimates and increasing our 12-month price target to $250, from $200."


Genius remains a top pick as we head into the December 3 Analyst Day... position Genius as a compounder with sustained +20% growth and rising FCF

Summary: Benchmark raises PT to $16, reiterates Top Pick on GENI: FanHub growth, in-play betting scale, prediction markets, and Analyst Day catalysts converging.

GENIUS SPORTS $GENI price-target raised to $16, reiterated as 'Top Pick' at Benchmark:

"Genius remains a top pick as we head into the December 3 Analyst Day. We see multiple catalysts converging: FanHub is inflecting as the most transformational growth driver, with ~60% media growth expected in 2H 2025 and agency adoption potentially expanding. In-play betting continues to scale, with BetVision driving mix shift and NFL exclusivity anchoring Genius’ role at the center of the ecosystem.

Prediction markets are emerging as an incremental opportunity, with the NFL making clear that official Genius data is required for legitimacy. The company has a consistent record of exceeding guidance and converting AEBITDA to FCF, and we expect Analyst Day to deliver more granular long-term targets, expanded disclosure around FanHub, and reinforcement of in-play adoption.

In our view, these catalysts, combined with structural scarcity in global sports data, position Genius as a compounder with sustained +20% growth and rising FCF."


Summary: Shares Canaccord PT raise to $13 on CIFR; bullish on AI data center deal, BTC mining efficiency, and power portfolio catalysts.

CIPHER MINING $CIFR price-target raised to $13 (from $9) at Canaccord Genuity:

"While CIFR stock has already responded to an uptick in AI data center activity recently, we believe there is still more to come. We believe a deal for the Barber Lake facility could be signed by the end of this year.

The bitcoin mining operation here is also one of the most profitable in existence, driven by leading fleet efficiency and some of the lowest cost of power in the industry. Optionality across Black Pearl P2 and what is potentially a very large power portfolio of emerging sites provides an ample set of valuation catalysts over the next few years, in our view.

Our new price target of $13 can be looked at more through a sum-of-the-parts lens, where Barber Lake is valued closely to peer companies that have signed data center deals (approximately $1.7B) and 2026 BTC mining revenue is valued at ~2x revenue or ~ $980M. End of Q2 1,063 bitcoin on the balance sheet is valued at $1.2B. This leaves ~$1.4 billion for the attractive 150MW Black Pearl P2 site and a site/power portfolio comprising multiple sites with the potential to provide up to 1.7GW of additional procured power over time."


Nebius will provide Microsoft with dedicated AI infrastructure capacity... total contract value is about $17.4 billion through 2031

Summary: NBIS signs $17.4B five-year AI infrastructure deal with MSFT, with potential upside to $19.4B; bullish for Nebius growth in 2026 and beyond.

*NEBIUS SIGNS $17.4 BILLION DOLLAR, FIVE-YEAR AGREEMENT WITH MICROSOFT FOR AI INFRASTRUCTURE $NBIS $MSFT

Nebius Group N.V. (NASDAQ: NBIS) announced a multi-year agreement to provide AI infrastructure services to Microsoft Corp. The deal involves delivering dedicated capacity from Nebius's new data center in Vineland, New Jersey, with services beginning later this year.

Under the agreement, Nebius will provide Microsoft with dedicated AI infrastructure capacity. The company operates as an AI infrastructure provider serving customers ranging from AI startups to enterprises.

"Nebius's core AI cloud business, serving customers from AI startups to enterprises, is performing exceptionally well," said Arkady Volozh, founder and CEO of Nebius. "I'm happy to announce the first of these contracts, and I believe there are more to come."

Nebius plans to finance the capital expenditure for the contract through cash flow from the deal and debt issuance secured against the contract. The company stated the debt terms would be enhanced by the credit quality of Microsoft as the counterparty.

The company indicated it is evaluating additional financing options to accelerate growth beyond original plans and will provide updates on its financing strategy. Volozh noted the deal would help accelerate the growth of Nebius's AI cloud business in 2026 and beyond.

FULL DETAILS:

On September 8, 2025, Nebius, Inc. (the “Company”), a wholly owned subsidiary of Nebius Group N.V. (“Nebius Group”), entered into a commercial agreement (the "Agreement") with Microsoft, pursuant to which the Company will provide Microsoft access to dedicated GPU infrastructure capacity in tranches (each, a “GPU Service”) at its new data center in Vineland, New Jersey (the “Data Center”) over a five-year term.

The GPU Services will be deployed in several tranches during 2025 and 2026. Subject to the satisfaction of the deployment and availability of the GPU Services, the total contract value is about $17.4 billion through 2031. Microsoft may also acquire additional services and/or capacity under the Agreement, which would increase the total contract value to about $19.4 billion. Cash flow coming from the Agreement will be utilized to finance part of the capital expenditure associated with the Agreement.

In the event that, following a grace period, Company fails to meet agreed delivery dates for a GPU Service and the Company cannot provide alternative capacity, Microsoft has the right to terminate that GPU Service. Either party may terminate the Agreement for cause due to the other party’s material breach (if not remedied within 60 days); or (ii) if the other party ceases doing business, terminates its existence, dissolves or liquidates, or proceedings are instituted by or against it under any bankruptcy or insolvency law (which proceedings are not dismissed within 30 days), provided that such right of termination shall not arise where a party has entered into Chapter 11 Bankruptcy and is undertaking reorganization or transfer activities in connection with such Chapter 11 Bankruptcy, including the transfer of the Agreement to a solvent entity.

The Agreement contains customary provisions for an agreement of this nature, including service level commitments, liquidated damages for late delivery, representations and warranties, indemnities, and limitations of liability. The obligations of the parties under the Agreement will commence upon the confirmation by Nebius to Microsoft that it has secured any additional financing required in respect of the capital expenditures under the Agreement.


Summary: Morgan Stanley elevates SanDisk to Top Pick, raises PT to $96 on eSSD demand surge, NAND pricing uplift, and above-consensus 2026 numbers.

SANDISK $SNDK price-target raised to $96 (from $70) at Morgan Stanley, named 'Top Pick':

"We elevate SanDisk to Top Pick and raise our price target to $96 as our prior bull case becomes our new base case. Recent strength in eSSD has caused a shift in the NAND market, as multiple hyperscalers have recently placed very large orders, 10s of exabytes, for NAND eSSDs.

That's more than enough to move the needle in the context of a market expected to be about 250-300EBs in total for all of calendar 2025. And while it is difficult to tell exactly what that kind of demand uplift will do for NAND pricing between now and year end, the rate of change vs prior investor expectations for flat to down pricing in Q4 should be sizeable.

With recent reports that SanDisk is already looking to raise prices 10% in channel and consumer markets, that view looks to be playing out, giving us incremental confidence in our above-consensus numbers for 2026 and in a higher multiple for the stock as AI begins to impact the narrative. SanDisk still needs to improve its position in eSSD, but we are optimistic that the BICs 8 transition may serve as a catalyst for their market share."


Amkor $AMKR
- Trades under 1x sales
- Testing 200-week SMA

Summary: Bullish AMKR: Broadcom/Apple/TSMC partnerships, Best Supplier Award, trades under 1x sales, testing 200-week SMA support.

Amkor $AMKR

- Broadcom $AVGO is designing OpenAI chips
- Amkor won 2024 'Best Supplier Award' from Broadcom
- Amkor partnered with Taiwan Semi $TSM & Apple $AAPL to launch largest OSAT hub in the U.S. -- Apple to be first customer
- Trades under 1x sales
- Testing 200-week SMA https://t.co/1UqCCaTAOp


Summary: Bullish AMKR as a key beneficiary of TSMC Arizona, Apple reshoring, and Broadcom AI chip packaging.

Soon, Amkor $AMKR will become synonymous with "TSMC Arizona", "Apple reshoring", and "Broadcom AI chips"


Summary: Shares JPMorgan OW initiation on CRSP with $70 Dec-2026 PT on Casgevy sales ramp, $2B cash, and milder preconditioning potential.

CRISPR THERAPEUTICS $CRSP initiated at 'Overweight' at JPMorgan, with a $70 price-target:

"We are launching coverage with an OW rating and a a Dec-2026 PT of $70. We believe CRSP warrants a new look from investors as it gets closer to several inflection points across its portfolio. At CRSP, where partnered Casgevy and ~ $2bn cash reserve offer good valuation support, the setup and outlook are vastly different from most of its gene-editing peers. Casgevy's levers today are indeed well understood. But as sales take off and net profits begin to flow into CRSP near term, coupled with the prospect of a milder precondition-ing, we see attractive potential for the company to gain additional credit for its stake in the franchise."


Summary: Bullish DPRO on thin float, breakout above 100-week MA, peers at 10-20x market cap, and catalyst-rich drone environment.

@Vmaxpax Cheers. Love DD snippets like this.

Just from a mechanical view:

- Lean 18m share float at a small $5 pps
- HVE pushing price above 100-week for first time ever
- Drone theme peers trading at 10-20x the mkt cap
- Catalyst rich environment

Pretty straightforward

Hard to disagree here.
One thing not mentioned much about $dpro is that it has a suite of products from s-UAS to heavy lift (Class 1 to 3) + vtol offerings.  All being validated at key DoD events this past summer https://t.co/XdHgeI3bF2


Summary: Holds DPRO as a live long position.

@captainkingjon @cg9999999999 I own it, search my tweets

@cg9999999999 @stocktalkweekly How about $DPRO


Summary: Bullish on Kratos following its midcap index inclusion; expects strong performance ahead.

@sam_badawi Midcap index, yes. Kratos is positioned to do very well.

@stocktalkweekly Rooting for $KTOS even though I’m not in it. Now part of the index!


Summary: Lake Street Capital initiates QUBT at Buy with $24 PT; author shares/adopts the bullish call.

QUANTUM COMPUTING $QUBT initiated at 'Buy' at Lake Street Capital, with a $24 price-target.


Summary: Shares bullish news that OpenAI will mass-produce in-house AI chips co-designed with Broadcom, shipping next year.

*OPENAI TO START MASS PRODUCTION OF ITS OWN IN-HOUSE AI CHIPS CO-DESIGNED WITH BROADCOM, PLANNING TO SHIP NEXT YEAR $AVGO


Summary: Shares Roth/MKM upgrade of LYFT to Buy with $19 PT on improving fundamentals, KPI records, and Freenow expansion.

LYFT $LYFT upgraded to 'Buy' (from Neutral) at Roth/MKM, with a $19 price-target:

"We are upgrading LYFT to Buy (from Neutral). Our PT goes up to $19 (from $16) driven by higher estimates and forwarding valuation framework to 2026. While 2Q Revs were a tad soft, ridesharing KPIs (rides, riders) and EBITDA/FCF margins reached all-time highs. 3Q guidance implies accelerating growth as Lyft integrates the Freenow acquisition and expands its presence overseas.

Lyft's fundamentals have turned a corner on GAAP basis (EPS & Op. Income). Given this fundamental progress, Lyft shares present a highly asymmetric investment opportunity, trading at 8.0x '26E Adj. EBITDA (or FCF) and ~12x '26E GAAP P/E."


ORACLE BACKLOG GREW +359% TO $455 BILLION — ORACLE CLOUD REVENUE EXPECTED TO GROW FROM $18 BILLION THIS YEAR TO $32 BILLION, $73 BILLION, $114 BILLION, AND THEN $144 BILLION OVER SUBSEQUENT FOUR YEARS

Summary: Shares Oracle's explosive backlog/cloud growth projections; framing implies durable multi-year bullish trajectory.

*ORACLE BACKLOG GREW +359% TO $455 BILLION

*ORACLE CLOUD REVENUE EXPECTED TO GROW +77% TO $18 BILLION THIS YEAR

*ORACLE CLOUD REVENUE EXPECTED TO GROW FROM $18 BILLION THIS YEAR TO $32 BILLION, $73 BILLION, $114 BILLION, AND THEN $144 BILLION OVER SUBSEQUENT FOUR YEARS

$ORCL


Summary: Bullish UUUU: successful dysprosium oxide pilot production validates it as a legitimate rare earth play.

Pretty awesome validation PR out this morning from Energy Fuels $UUUU -- makes it a legit rare earth play.

"Energy Fuels Inc., a leading U.S. producer of uranium, rare earths, and critical minerals, is pleased to announce that it has successfully completed production of its first kilogram of dysprosium (Dy) oxide at pilot scale at the Company's White Mesa Mill in Utah. The Company achieved a purity of 99.9% Dy, which is well in excess of the 99.5% commercial specification.

The Mill expects to continue producing dysprosium oxide at a rate of two (2) kilograms per week. Energy Fuels believes it is the first U.S. company to both produce high-purity Dy oxide and publicly disclose actual production volumes and purities.

These oxides are being produced from monazite mined in Florida and Georgia, USA and demonstrate the expected viability of Energy Fuels' completely non-Chinese rare earth oxide supply chain. Multiple magnet manufacturers and OEMs have already expressed their strong interest in obtaining these samples to accelerate their validation processes.

Energy Fuels believes the quantity and purity of its Dy oxide production is unmatched in the United States at this time and is a testament to the White Mesa Mill's world-class rare earth element (REE) production capabilities. Pilot-scale production is expected to continue until approximately 15 kilograms of Dy oxide are produced. At that point, Energy Fuels intends to produce high purity terbium (Tb) oxide and is targeting Q4-2025 for the first samples of Tb oxide to be available for end-user validation.

Due to the ongoing success of this "heavy" REE pilot project, the Company intends to construct and commission commercial-scale Dy, Tb, and potentially other "heavy" REE separation capacity at its White Mesa Mill, which could be in production as soon as Q4 2026.

"Energy Fuels' high purity Dy oxide production is a major leap toward securing a U.S. supply of 'heavy' rare earth oxides for a variety of commercial and defense uses," said Energy Fuels CEO Mark S. Chalmers. "This is real, high-quality material in-hand, ready for independent testing, demonstrating that our Utah facilities can deliver world-class critical minerals domestically. Data and knowledge from our pilot plants will guide the design and construction of commercial Dy, Tb, and potentially other 'heavy' rare earth separation infrastructure that we plan to install in Utah next year."


Summary: Shares Loop Capital Buy reiteration on PLTR with PT raised to $178, citing beat-and-raise trajectory, AI leadership, scarcity value, and government tailwinds.

PALANTIR $PLTR price-target raised to $178 (from $155) at Loop Capital. while maintaining a 'Buy' rating:

"Based on our checks, we expect PLTR to deliver another beat and raise, with revenue outperformance in line with or exceeding the 5-quarter average upside of 4.3% above the midpoint of guidance.

Additionally, we anticipate guidance to increase beyond the past four-quarter average of 2.3%. The hard part is to guess whether that will be enough to satisfy investors who have pushed the stock straight up and to the right — rising 106% ytd and 26% since the 1Q earnings release — which is the kind of chart that gives us pause buying ahead of the print.

The company's eye-popping valuation is supported by the combination of demonstrated AI leadership, scarcity value as one of the few pure-play AI software stocks, and category-leading margins. Market sentiment around AI names remains highly favorable, and Palantir benefits from its unique position at the intersection of artificial intelligence and enterprise software. The company continues to secure significant commercial contracts as pilot programs scale into full production, with AI use cases expanding exponentially across industries.

Additionally, Palantir’s established government footprint and strong ties with senior members of the Trump administration are expected to bolster growth in its federal business, especially as efforts to modernize U.S. government operations and implement strategic policies such as tax reform and defense initiatives advance.

Together, these factors have driven best-in-class revenue growth and margins — exemplified by a rule of 81 score in 1Q25 and a 68 score in 2024 — solidifying its position as an AI leader with significant growth potential.

Our checks and earlier meeting with management suggest Palantir's momentum continues, and we expect the stock to move higher over the long term, if only because the firm delivers best-in-class revenue growth plus margins, and faces a decade-plus cycle similar to previous watershed shifts like the PC revolution or cloud computing."


Summary: Bullish DFH: cheap valuation (0.6x sales, 9x P/E), 20% revenue growth, accumulative volume profile, high short float, and recovering above key MAs.

Dream Finders Homes $DFH

Asset-light home builder with TTM revenue growth of +20%, trading at just 0.6x sales & 9.0 P/E. Volume profile is clearly accumulative for the lifetime of the stock. Float is 18% short. Defended 200-week and now poking head above 100-week moving avg. https://t.co/7DEGUuHXX0


Summary: Shares Citibank Buy reiteration on DLO with PT raised to $17 (~21% upside) on strong 2Q25 results and upgraded 2025 guidance.

DLOCAL $DLO price-target raised to $17 (from $14.60) at Citibank:

"We adjust our estimates after the strong 2Q25 results, also considering the upgraded guidance for 2025. With that, we raise our net income expectations by 13% for 2025 and 5% for 2026. While volumes are decelerating on tougher comps base, we still see solid growth potential ahead (+33% in ’26E). We reiterate our Buy/HR rating and increase our TP to US$17.00 – implying ~21% upside potential. Trading at 18.6x P/E for 2026E, we see DLO as decent for a growth case."


Summary: Shares Cantor's reiterated $12 PT on Aurora Innovation on autonomous trucking progress and route expansion.

$AUR re-testing the 200-day moving average. Cantor reiterated $12 PT on Aug. 4 noting the company has three driverless trucks now operating between Dallas and Houston (including at night) with no interventions. Opened PHX terminal and plans to expand Texas routes to FTW-El Paso. https://t.co/Mjo6iO0S0B


Summary: Long LYFT via longer-dated contracts, targeting $17.17 (200-week MA) as key upside level.

@zohmbastic Prob needs to re-test 50 SMA break on daily chart, but I'm in longer dated contracts so looking at $17.17 (200-week) as big spot.

@stocktalkweekly $LYFT thinking 15.55-15.6 trim zone


Summary: Long KTOS as core drone position for 1+ year, still favorite; also added DPRO last week.

@SRxTrades $KTOS has been my core position in this theme for a year+, remains my favorite, but don't forget to add $DPRO to your list too.

Got in last week.

https://t.co/BV5q5D2S6j

Drone stocks

Starting to breakout of their big weekly bases

Still a ton of upside potential left in this theme

$UMAC Target: $19
$RCAT Target: $15
$AEHR Target: $46
$KTOS Target: $92 https://t.co/9t82TbSDZU


don't forget to add $DPRO to your list too. Got in last week.


rare national strategic assets possessed by companies like Centrus (Piketon Enrichment Faciity) deserve premium valuations

Summary: National policy supports premium valuations for Centrus and Energy Fuels as rare strategic nuclear assets; pre-rev SMRs harder to justify.

@UnoMasReactor Agreed & it's also easier to argue that in light of recent national policy that the rare national strategic assets possessed by companies like Centrus (Piketon Enrichment Faciity) & Energy Fuels (White Mesa Mill) deserve premium valuations. Tougher to argue that for pre-rev SMRs

@stocktalkweekly Can't drive the car if there's no gas station  🧠


rare national strategic assets possessed by companies like ... Energy Fuels (White Mesa Mill) deserve premium valuations


Summary: Still long DOCN; endorses AI/ML scaler thesis with strong monthly chart setup.

@ruth_capital Nice to see you on this one too, Ruth (especially after $DPRO has done us so well)

Picked it up mid Sept., still long. Great monthly look.

https://t.co/bmneaqGDgT

I'm closely watching $DOCN as AI/ML scaler play for '26 - excellent recent analyst coverage

monthly chart looks strong - IPO AVWAP at 44.66, 50EMA at 40.69, with solid volume flux

beyond biotech, thermal, metallurgical assets, and commodities, select tech names will be re-rated


Summary: BofA raises HOOD PT to $139 from $119; author shares/adopts the bullish call.

*ROBINHOOD $HOOD PRICE-TARGET RAISED TO $139 (FROM $119) AT BANK OF AMERICA


Summary: Shares Baird upgrade of ORA to Outperform with PT raised to $103 on geothermal policy tailwinds and higher PPA repricing.

ORMAT TECHNOLOGIES $ORA upgraded to 'Outperform' (from Neutral) at Baird, with a $103 price-target (from $87):

"Upgrading to Outperform. We are incrementally positive on ORA given support of US politicians for geothermal power production/development. Recall that we initiated coverage of ORA late in Q1 with a Neutral rating and positive bias, noting that the permanence of IRA incentives were a factor keeping us from Outperform.

With geothermal gaining support and favorable treatment in the BBB, we are becoming more constructive. Upside to long-term financial targets may stem from PPAs which are being renegotiated at higher prices (particularly with hyperscalers)."


Summary: Baird raises TSLA PT to $548 (+70%), upgrades to Outperform, calling Tesla leader in physical AI despite near-term choppiness.

*TESLA $TSLA PRICE-TARGET INCREASED BY +70% AT BAIRD TO $548 (FROM $320)

Analyst Ben Kallo calls Tesla the "leader in physical AI":

"Relatively muted stock reactions following a series of less than stellar quarters and investor inbounds regarding long-term initiatives lead us to believe focus has increasingly shifted to the future for TSLA. The recently proposed pay package is built on lofty targets for both product rollout and market cap. In addition to our upgrade, we use this note to illustrate the implications of each milestone on financials and are publishing a hypothetical "pay package" model to frame the opportunity.

Despite three consecutive quarters of missing estimates (or meeting estimates that were revised downward), TSLA is up 10% YTD (vs. the S&P 500 up 13%) and has gained 24% in the last month vs. 3%, respectively. Maintaining our view that volumes will likely decline again in full-year 2025 and near-term fundamentals will be choppy, we now expect shares to Outperform as TSLA is increasingly viewed as the leader in physical AI."


Summary: Long AMKR as the single best SMID-cap play on US semiconductor re-shoring; broader market yet to realize it.

Not a single soul on this platform was talking about Amkor $AMKR when I posted this two weeks ago.

Go search the ticker for yourself.

Stock is now +18% higher.

Soon, broader mkt will realize this is single-best SMID cap exposure to play U.S. semiconductor re-shoring.


Summary: Bullish CLPT on high-volume expansion + multi-year range breakout signal.

@fullbidlift HVE last month, by a wide margin too. That's usually bullish, especially paired with a multi-year range break

@stocktalkweekly $CLPT, peer to Neuralink. Robust pipeline of uses


Summary: Bullish EOSE; chart signals much higher prices ahead.

@400kProject Nope, but its a name I like a lot and a chart that says "much higher"


Summary: Trump admin considering stake in Critical Metals; relayed as bullish catalyst for CRML.

*TRUMP ADMIN CONSIDERING STAKE IN GREENLAND RARE EARTH MINER CRITICAL METALS $CRML


Summary: Shares/endorses Jefferies Buy initiation on ETR, PT $109, citing 11-15% EPS CAGR and hyperscaler demand visibility through 2031+.

ENTERGY CORP $ETR initiated at 'Buy' at Jefferies with a $109 price-target, calling it the "clearest regulated beneficiary of hyperscaler demand":

"Best-positioned AI load play with 11-15% EPS CAGR 2024-2030, faster than every utility peer. +7-11% above Street in 2028+. Trades at peer average FY28 P/E on JEFe: meaningfully undervalued.

ETR is the clearest regulated beneficiary of hyperscaler demand: ~8 GW contracted (META, AMZN, & potentially GOOGL) &~7 GW turbines reserved, giving visibility through 2031+. Vertically integrated model, Gulf Coast siting, & standardized CCGTs de-risk plan."


Summary: RBC reiterates Outperform on LYFT with $21 PT on ride-hail growth, AV strategy via Freenow, and attractive 8.5x EV/EBITDA valuation.

$LYFT reiterated at 'Outperform' at RBC Capital, with a $21 price-target:

"We hosted investor meetings with LYFT's CEO and VP of FP&A/IR. Discussion topics mostly centered around unpacking the various North America ride-hail growth opportunities, AV progress & strategy, international expansion plans through the Freenow acquisition, recent governance changes and capital allocation, particularly in the context of a perceived attractive valuation.

We remain constructive on the stock as the company has several shots on goal to drive durable core ride-hail growth, its ability to address AVs is greatly expanded through Freenow and the company's margin leverage & strong cash flow set it up to return more capital where the buyback is arguably too low while the stock trades at 8.5x EV/'26E EBITDA and 5.7x the company's 2027 EBITDA target."